SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,025,000 | -89.8% | 41,900 | -76.6% | 0.72% | -95.7% |
Q4 2017 | $29,516,000 | +148.8% | 179,200 | -5.9% | 16.65% | +170.4% |
Q3 2017 | $11,862,000 | +148.3% | 190,400 | +217.3% | 6.16% | +171.0% |
Q2 2017 | $4,778,000 | -34.6% | 60,000 | -41.6% | 2.27% | -44.4% |
Q1 2017 | $7,306,000 | +327.0% | 102,800 | +81.0% | 4.09% | +367.6% |
Q2 2016 | $1,711,000 | – | 56,800 | – | 0.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 181,650 | $15,715,000 | 7.17% |
GREAT POINT PARTNERS LLC | 454,417 | $39,312,000 | 6.38% |
ACUTA CAPITAL PARTNERS, LLC | 255,800 | $22,129,000 | 6.02% |
Integral Health Asset Management, LLC | 195,000 | $16,869,000 | 5.02% |
DAFNA Capital Management LLC | 181,306 | $15,685,000 | 4.67% |
Boxer Capital, LLC | 1,094,000 | $94,642,000 | 3.04% |
Palo Alto Investors LP | 590,200 | $51,058,000 | 2.68% |
Bellevue Group AG | 1,567,504 | $135,604,000 | 1.55% |
Aristotle Atlantic Partners, LLC | 160,805 | $13,911,000 | 1.07% |
JGP Global Gestao de Recursos Ltda. | 2,618 | $226,000 | 0.85% |